HHS Secretary Questioning

Concerns Regarding Transparency and Scientific Integrity at HHS

Allegations of Waste, Abuse, and Illegality at NIH

  • Representative Pelon raises concerns about the Secretary's actions and the budget, arguing they will not improve the country's health.
  • Points to a letter signed by 340 scientists detailing waste, abuse, and illegality at NIH under the previous administration.

Anti-Science Agenda and Vaccine Concerns

  • Accusations that the Secretary holds dangerous views on vaccines not supported by scientific evidence.
  • Requests unanimous consent to enter letters from 63 medical and public health groups, as well as organizations like the American Academy of Family Physicians and the American Academy of Pediatrics, into the record, all expressing concerns about the Secretary's actions on vaccines.
  • The central argument is that the Secretary's policies and stances are endangering public health.

Lack of Transparency and Congressional Oversight

  • Accusations that the Secretary promotes unfounded therapies and conspiracy theories without data or evidence, all behind closed doors.
  • Despite pledges of "radical transparency," the Secretary has allegedly failed to keep Congress informed or answer inquiries.
  • Representative Pelon mentions sending 10 letters on various topics, including workforce and program cuts at HHS, that have gone unanswered.
  • Pelon describes the Secretary's actions as "radical obstruction of congressional oversight."

Commitment to Respond to Congressional Inquiries

  • Representative Pelon presses the Secretary for a commitment to provide written responses to the unanswered letters by a specific date (August 1).
  • The Secretary responds that they are working to answer the thousands of letters received from Congress but does not commit to a specific date, leading to skepticism from Representative Pelon.

Vaccine Policies and Public Input

  • Concerns raised about major decisions regarding vaccines being made without public comment or accountability.
  • Representative Pelon questions whether the Secretary is afraid of receiving public comments that might contradict their views.
  • The Secretary defends the process by referring to the AZIP committee, stating that it involves public meetings and funded meetings.
  • The Secretary states that individuals with conflicts of interest with the pharmaceutical industry were removed from the AZIP committee.

Overall Assessment

  • Representative Pelon expresses a complete lack of faith in the Secretary's transparency and accuses them of promoting an anti-science, anti-vaccine ideology.
  • The exchange ends with Representative Pelon yielding time, expressing frustration at the perceived lack of responsiveness and accountability.